Pages that link to "Q68056139"
Jump to navigation
Jump to search
The following pages link to Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project (Q68056139):
Displaying 50 items.
- Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progression-free survival in patients with advanced and/or metastatic colorectal cancer (Q24186145) (← links)
- Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for advanced and/or metastatic colorectal cancer (Q24200737) (← links)
- Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for advanced and/or metastatic colorectal cancer (Q24234555) (← links)
- Identification and characterization of human mitochondrial methenyltetrahydrofolate synthetase activity (Q24320089) (← links)
- Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer (Q24795149) (← links)
- Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer (Q24795784) (← links)
- Phase I study of intermittent and chronomodulated oral therapy with capecitabine in patients with advanced and/or metastatic cancer (Q25256709) (← links)
- Oral versus intravenous fluoropyrimidines for metastatic colorectal cancer (Q26472148) (← links)
- Current targeted therapies in the treatment of advanced colorectal cancer: a review (Q26740067) (← links)
- Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancer (Q26771952) (← links)
- Precision medicine in colorectal cancer: the molecular profile alters treatment strategies (Q26795558) (← links)
- Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial (Q28036747) (← links)
- 5-Fluorouracil: mechanisms of action and clinical strategies (Q28201937) (← links)
- Thymidylate synthase as a translational regulator of cellular gene expression (Q28207340) (← links)
- Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism (Q28207364) (← links)
- 8-Cl-adenosine-induced inhibition of colorectal cancer growth in vitro and in vivo (Q28350637) (← links)
- Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid (Q28370847) (← links)
- An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer. (Q31106341) (← links)
- Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer (Q31879843) (← links)
- Meta-analysis when only the median survival times are known: a comparison with individual patient data results (Q33212361) (← links)
- Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: a Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study (Q33332077) (← links)
- Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer (Q33363451) (← links)
- A phase II study of capecitabine plus oxaliplatin (XELOX): a new first-line option in metastatic colorectal cancer (Q33366181) (← links)
- The efficacy of a modified chronomodulated infusion of oxaliplatin, 5-fluorouracil and leucovorin in advanced colorectal cancer (preliminary data). (Q33389163) (← links)
- Contributions of meta-analyses based on individual patient data to therapeutic progress in colorectal cancer (Q33434559) (← links)
- Phase II trial of echinomycin in patients with advanced or recurrent colorectal cancer (Q33491521) (← links)
- Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer (Q33499176) (← links)
- A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer (Q33501101) (← links)
- Oxaliplatin: a review of its use in the management of metastatic colorectal cancer (Q33688811) (← links)
- Is there a standard chemotherapeutic strategy in colorectal cancer? (Q33706287) (← links)
- Does biomodulation of 5-fluorouracil improve results? (Q33711597) (← links)
- A review of the pharmacology and clinical activity of new chemotherapy agents for the treatment of colorectal cancer (Q33746097) (← links)
- Phase II study of irinotecan, 5-fluorouracil, and leucovorin in relapsed or metastatic colorectal cancer as first-line therapy (Q33746897) (← links)
- Combination of raltitrexed with other cytotoxic agents: rationale and preclinical observations (Q33822780) (← links)
- Should chemotherapy be used as a treatment of advanced colorectal carcinoma (ACC) in patients over 70 years of age? (Q33837320) (← links)
- Multidisciplinary management of recurrent colorectal cancer (Q33839180) (← links)
- In vivo monitoring of drugs using radiotracer techniques (Q33852953) (← links)
- Tegafur/uracil + calcium folinate in colorectal cancer: double modulation of fluorouracil (Q33859971) (← links)
- Evolution in the treatment of metastatic colorectal carcinoma of the liver (Q33868416) (← links)
- Basis for effective combination cancer chemotherapy with antimetabolites (Q33919546) (← links)
- 5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development (Q33925505) (← links)
- Treatment of colon and rectal cancer (Q33932019) (← links)
- Recent advances in cancer chemotherapy (Q33967932) (← links)
- The role of meta-analyses in assessing cancer treatments (Q33971420) (← links)
- A Phase II Study of Oxaliplatin, Dose-intense Capecitabine, and High-dose Bevacizumab in the Treatment of Metastatic Colorectal Cancer (Q33998072) (← links)
- Capecitabine, a new oral fluoropyrimidine for the treatment of colorectal cancer (Q33998349) (← links)
- Quality control of oncology clinical trials. (Q34009234) (← links)
- Progress in colorectal cancer chemotherapy: how far have we come, how far to go? (Q34067396) (← links)
- Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies (Q34086049) (← links)
- Pemetrexed disodium, a novel antifolate with multiple targets (Q34119634) (← links)